8-K

Company

Cellectar Biosciences, Inc.

Filed

September 29, 2017

Period of Report

September 29, 2017

Accession Number

0001144204-17-050522

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →